Reaction
Myelodysplastic Syndrome With Excess Blasts reporting signals
As of the last recalculation, Myelodysplastic Syndrome With Excess Blasts appears in 116 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TRETINOIN (PRR 189.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tretinoin | 8 | 189.9 | 190.1 |
| Melphalan | 19 | 179.0 | 179.2 |
| Melphalan Hydrochloride | 19 | 162.4 | 162.5 |
| Thiotepa | 7 | 139.9 | 140.0 |
| Erythropoietin | 13 | 127.7 | 127.8 |
| Olaparib | 12 | 114.7 | 114.8 |
| Axicabtagene Ciloleucel | 5 | 95.0 | 95.0 |
| Azacitidine For | 8 | 84.7 | 84.7 |
| Azacitidine | 11 | 73.4 | 73.4 |
| Carfilzomib | 9 | 61.8 | 61.8 |